BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1296 related articles for article (PubMed ID: 19387125)

  • 1. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do women in the U.S. know about human papillomavirus and cervical cancer?
    Tiro JA; Meissner HI; Kobrin S; Chollette V
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):288-94. PubMed ID: 17267388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's knowledge about human papillomavirus and their acceptance of HPV vaccine.
    Dursun P; Altuntas B; Kuscu E; Ayhan A
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):202-6. PubMed ID: 19432612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium.
    Donders GG; Gabrovska M; Bellen G; Van Keirsbilck J; Van Den Bosch T; Riphagen I; Verjans M
    Arch Gynecol Obstet; 2008 Apr; 277(4):291-8. PubMed ID: 17965870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do cervical cancer screening patient information leaflets meet the HPV information needs of women?
    Hall B; Howard K; McCaffery K
    Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's knowledge about cervical cancer, Pap smear and human papillomavirus and its relation to screening in Argentina.
    Paolino M; Arrossi S
    Women Health; 2011 Jan; 51(1):72-87. PubMed ID: 21391162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human papillomavirus in women over 40: implications for practice and recommendations for screening.
    Montgomery K; Bloch JR
    J Am Acad Nurse Pract; 2010 Feb; 22(2):92-100. PubMed ID: 20132367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young adults and acceptance of the human papillomavirus vaccine.
    Lenselink CH; Schmeink CE; Melchers WJ; Massuger LF; Hendriks JC; van Hamont D; Bekkers RL
    Public Health; 2008 Dec; 122(12):1295-301. PubMed ID: 18619631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results.
    Kahn JA; Slap GB; Bernstein DI; Kollar LM; Tissot AM; Hillard PA; Rosenthal SL
    J Womens Health (Larchmt); 2005 Sep; 14(7):650-9. PubMed ID: 16181021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
    Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
    BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy.
    Massad LS; Verhulst SJ; Hagemeyer M; Brady P
    J Low Genit Tract Dis; 2006 Oct; 10(4):252-5. PubMed ID: 17012992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.